Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models

Helena Ågerstam, Nils Hansen, Sofia von Palffy, Carl Sandén, Kristian Reckzeh, Christine Karlsson, Henrik Lilljebjörn, Niklas Landberg, Maria Askmyr, Carl Högberg, Marianne Rissler, Kimmo Porkka, Hans Wadenvik, Satu Mustjoki, Johan Richter, Marcus Järås, Thoas Fioretos

Blood (2016) 128 (23): 2683–2693.

https://doi.org/10.1182/blood-2015-11-679985

Published: 2016

Includes: Supplemental data

Journal Articles

IL1RAP Antibodies Block IL1-Induced Expansion of Primitive CML Cells and Display Therapeutic Effects in Xenograft Models

Helena Ågerstam, Nils Hansen, Sofia Von Palffy, Carl Sandén, Kristian Reckzeh, Christine Karlsson, Henrik Lilljebjörn, Niklas Landberg, Maria Askmyr, Carl Högberg, Marianne Rissler, Kimmo Porkka, Hans Wadenvik, Satu Mustjoki, Johan Richter, MD, Marcus Järås, Thoas Fioretos

Blood (2016) 128 (22): 1118.

https://doi.org/10.1182/blood.V128.22.1118.1118

Published: 2016

Journal Articles

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Niklas Gunnarsson, MD, Martin Höglund, MD PhD, Leif Stenke, MD PhD, Fredrik Sandin, MSc, Magnus Bjorkholm, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevärn, MD, Ulla Olsson-Strömberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD, Anders Själander, MD PhD

Blood (2016) 128 (22): 1896.

https://doi.org/10.1182/blood.V128.22.1896.1896

Published: 2016

Journal Articles

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Niklas Gunnarsson, MD, Martin Hoglund, MD PhD, Leif Stenke, MD PhD, Solveig Wallberg Jonsson, MD PhD, Fredrik Sandin, PhD, Magnus Bjorkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevarn, MD, Ulla Olsson-Stromberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD PhD, Anders Sjalander, MD PhD

Blood (2015) 126 (23): 1586.

https://doi.org/10.1182/blood.V126.23.1586.1586

Published: 2015

Journal Articles

Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Niklas Gunnarsson, MD, Stenke Leif, MD PhD, Martin Höglund, MD PhD, Fredrik Sandin, PhD, Magnus Björkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevärn, MD, Ulla Olsson-Strömberg, MD PhD, Johan Richter, MD PhD, Hans Wadenvik, MD PhD, Jonas Wallvik, MD PhD, Anders Själander, MD PhD

Blood (2014) 124 (21): 154.

https://doi.org/10.1182/blood.V124.21.154.154

Published: 2014

Journal Articles

Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP

Margareta Jernås, Yu Hou, Frida Strömberg Célind, Linlin Shao, Intawat Nookaew, Qian Wang, Xiuli Ju, Karin Mellgren, Hans Wadenvik, Ming Hou, Bob Olsson

Blood (2013) 122 (10): 1789–1792.

https://doi.org/10.1182/blood-2013-05-502807

Published: 2013

Includes: Supplemental data

Journal Articles

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Blood (2013) 122 (7): 1284–1292.

https://doi.org/10.1182/blood-2013-04-495598

Published: 2013

Journal Articles

MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP)

Margareta Jernås, Intawat Nookaew, Hans Wadenvik, Bob Olsson

Blood (2013) 121 (11): 2095–2098.

https://doi.org/10.1182/blood-2012-12-471250

Published: 2013

Includes: Supplemental data

Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice – Interim Results From a Large, European, Observational Study

Dominik Selleslag, Ann Janssens, Hans Wadenvik, Michael Steurer, MD, Philippe Quittet, MD, Georgia Kaiafa, Tomas Kozak, MD, Helen Papadaki, Jean-François Viallard, MD, PhD, Kerry Dillingham, Georg Kreuzbauer, MD

Blood (2012) 120 (21): 3316.

https://doi.org/10.1182/blood.V120.21.3316.3316

Published: 2012

Journal Articles

A Comparative Gene Expression Study of CD3+ T-Cells In Bone Marrow From Patients with Chronic ITP and Healthy Controls by DNA Microarray.

Margareta Jernås, Bob Olsson, Hans Wadenvik

Blood (2010) 116 (21): 1445.

https://doi.org/10.1182/blood.V116.21.1445.1445

Published: 2010

Journal Articles

Increased Number of B-Cells In the Red Pulp of the Spleen In ITP

Bob Olsson, Hans Wadenvik, Margareta Jernås, Börje Ridell

Blood (2010) 116 (21): 1447.

https://doi.org/10.1182/blood.V116.21.1447.1447

Published: 2010

Journal Articles

CD69 as a Surrogate Marker for IgVH Gene Mutation Status in Chronic Lymphocytic Leukaemia (CLL)

Bob Olsson, Sofia Grund, Margareta Jernås, Stefan Jacobsson, Lena Carlsson, Hans Wadenvik

Blood (2008) 112 (11): 4160.

https://doi.org/10.1182/blood.V112.11.4160.4160

Published: 2008

Journal Articles

Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1

Bob Olsson, Börje Ridell, Lena Carlsson, Stefan Jacobsson, Hans Wadenvik

Blood (2008) 112 (4): 1078–1084.

https://doi.org/10.1182/blood-2008-02-139402

Published: 2008

Journal Articles

Increased Cortical Bone Mineralization in Imatinib Treated Patients with Chronic Myelogenous Leukemia.

Sofia Jonsson, MD, Yuan Wei, Ph.D., Bob Olsson, Ph.D., Claes Ohlsson, M.D., Ph.D., Mattias Lorentzon, M.D., Ph.D., Dan Mellstrom, M.D., Ph.D., Hans Wadenvik, M.D., Ph.D.

Blood (2007) 110 (11): 2940.

https://doi.org/10.1182/blood.V110.11.2940.2940

Published: 2007

Journal Articles

Quantitative Analyses of BCR-ABL Mutations Associated with Imatinib Treatment in CML.

Franz Gruber, MD, Henrik Hjort Hansen, MD, Marita Olsen, Lab.tech., Lene Eggen, Lab.tech., Bjørn Skogen, MD, Tobias Gedde-Dahl, MD, Tuija Lundan, MD, Kimmo Porkka, MD, Bengt Simonsson, MD, Berit Markevärn, MD, Hans Wadenvik, MD, Leif Stenke, MD

Blood (2005) 106 (11): 2000.

https://doi.org/10.1182/blood.V106.11.2000.2000

Published: 2005

Journal Articles

Multiple Quinine-Dependent Antibodies in a Patient With Episodic Thrombocytopenia, Neutropenia, Lymphocytopenia, and Granulomatous Hepatitis

Ming Hou, Eva Horney, Dick Stockelberg, Stefan Jacobsson, Jack Kutti, Hans Wadenvik

Blood (1997) 90 (12): 4806–4811.

https://doi.org/10.1182/blood.V90.12.4806

Published: 1997

NARROW

IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models

IL1RAP Antibodies Block IL1-Induced Expansion of Primitive CML Cells and Display Therapeutic Effects in Xenograft Models

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP)

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice – Interim Results From a Large, European, Observational Study

A Comparative Gene Expression Study of CD3+ T-Cells In Bone Marrow From Patients with Chronic ITP and Healthy Controls by DNA Microarray.

Increased Number of B-Cells In the Red Pulp of the Spleen In ITP

CD69 as a Surrogate Marker for IgVH Gene Mutation Status in Chronic Lymphocytic Leukaemia (CLL)

Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1

Increased Cortical Bone Mineralization in Imatinib Treated Patients with Chronic Myelogenous Leukemia.

Quantitative Analyses of BCR-ABL Mutations Associated with Imatinib Treatment in CML.

Multiple Quinine-Dependent Antibodies in a Patient With Episodic Thrombocytopenia, Neutropenia, Lymphocytopenia, and Granulomatous Hepatitis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only